AstraZeneca Plc is increasingly looking to the US for growth as its once fast-expanding China business faces challenges amid ...

Profit after tax came in ₹38.4 crore in Q2 of FY25, a recovery from a net loss of ₹11.8 crore in the first quarter of this ...

AZN beats third-quarter estimates for earnings and sales. It raises its sales and profit outlook for 2024 for the second time ...

AstraZeneca said it plans to pump $2 billion in new investment ... parts of which are aimed at lowering drug prices. The ...

The company said it aims to expand its U.S. presence by the end of 2026. The new spending will be for a research-and-development center in Cambridge, Mass.; manufacturing plants in Maryland and Texas, ...

BRITS on a budget are to face even higher prices at discount shops such as Aldi and Lidl because of the Chancellor’s tax raid ...

Aarti Industries, Aditya Birla Fashion Retail, Granules India, Hindustan Copper, Manappuram Finance are banned from F&O trading on 13 November 2024.

Copyright 2024 Alliance News Ltd. All Rights Reserved.

Since its approval in 2019, Brukinsa’s stronger efficacy and superior safety profile have allowed BeiGene to gain market share from existing drugs ... Unlike some other Chinese drug companies, we ...

Akshay Kumar added a Toyota Vellfire to his impressive car collection. The actor was recently spotted alongside Suniel Shetty and Paresh Rawal outside Mumbai airport as he arrived in his new ...

London stocks fell sharply on Tuesday as investors digested recent UK employment data alongside broader market reactions to ...

AstraZeneca ( (AZN) ) has released its Q3 earnings. Here is a breakdown of the information AstraZeneca presented to its investors. AstraZeneca ...